ATG Individualized Dosing Model in URD-PBSCT.

NCT06572462 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Cytomegalovirus Infections
Infection Reactivation
Stem Cell Transplant Complications

Interventions

DRUG: individualized ATG dosing strategy

Sponsor

Chinese PLA General Hospital